Functional interaction of lithocholic acid conjugates with M3 muscarinic receptors on a human colon cancer cell line
- PMID: 12379313
- DOI: 10.1016/s0925-4439(02)00115-1
Functional interaction of lithocholic acid conjugates with M3 muscarinic receptors on a human colon cancer cell line
Abstract
Lithocholic acid (LA) conjugates interact with M3 receptors, the muscarinic receptor subtype that modulates colon cancer cell proliferation. This observation prompted us to examine the action of bile acids on two human colon cancer cell lines: H508, which expresses M3 receptors, and SNU-C4, which does not. Cellular proliferation was determined using a colorimetric assay. Interaction with muscarinic receptors was determined by measuring inhibition of muscarinic radioligand binding and changes in cellular inositol phosphate (IP) formation. Lithocholyltaurine (LCT) caused a dose-dependent increase in H508 cell proliferation that was not observed in SNU-C4 cells. After a 6-day incubation with 300 microM LCT, H508 cell proliferation increased by 200% compared to control. Moreover, in H508 cells, LCT caused a dose-dependent inhibition of radioligand binding and an increase in IP formation. LCT did not alter the rate of apoptosis in H508 or SNU-C4 cells. These data indicate that, at concentrations achievable in the gut, LA derivatives interact with M3 muscarinic receptors on H508 human colon cancer cells, thereby causing an increase in IP formation and cell proliferation. This suggests a mechanism whereby alterations in intestinal bile acids may affect the growth of colon cancer cells.
Similar articles
-
Selective interaction of bile acids with muscarinic receptors: a case of molecular mimicry.Eur J Pharmacol. 2002 Dec 20;457(2-3):77-84. doi: 10.1016/s0014-2999(02)02690-0. Eur J Pharmacol. 2002. PMID: 12464352
-
Lithocholylcholine, a bile acid/acetylcholine hybrid, is a muscarinic receptor antagonist.J Pharmacol Exp Ther. 2002 Oct;303(1):29-35. doi: 10.1124/jpet.102.036376. J Pharmacol Exp Ther. 2002. PMID: 12235229
-
Transactivation of the epidermal growth factor receptor mediates cholinergic agonist-induced proliferation of H508 human colon cancer cells.Cancer Res. 2003 Oct 15;63(20):6744-50. Cancer Res. 2003. PMID: 14583469
-
Activation of muscarinic receptor signaling by bile acids: physiological and medical implications.Dig Dis Sci. 2003 Aug;48(8):1431-44. doi: 10.1023/a:1024733500950. Dig Dis Sci. 2003. PMID: 12924634 Review.
-
Differential Actions of Muscarinic Receptor Subtypes in Gastric, Pancreatic, and Colon Cancer.Int J Mol Sci. 2021 Dec 5;22(23):13153. doi: 10.3390/ijms222313153. Int J Mol Sci. 2021. PMID: 34884958 Free PMC article. Review.
Cited by
-
Farnesoid X receptor represses matrix metalloproteinase 7 expression, revealing this regulatory axis as a promising therapeutic target in colon cancer.J Biol Chem. 2019 May 24;294(21):8529-8542. doi: 10.1074/jbc.RA118.004361. Epub 2019 Apr 9. J Biol Chem. 2019. PMID: 30967475 Free PMC article.
-
Acetylcholine-induced activation of M3 muscarinic receptors stimulates robust matrix metalloproteinase gene expression in human colon cancer cells.Am J Physiol Gastrointest Liver Physiol. 2009 Apr;296(4):G755-63. doi: 10.1152/ajpgi.90519.2008. Epub 2009 Feb 12. Am J Physiol Gastrointest Liver Physiol. 2009. PMID: 19221016 Free PMC article.
-
Bile acids are nutrient signaling hormones.Steroids. 2014 Aug;86:62-8. doi: 10.1016/j.steroids.2014.04.016. Epub 2014 May 10. Steroids. 2014. PMID: 24819989 Free PMC article. Review.
-
Overcoming Obstacles to Targeting Muscarinic Receptor Signaling in Colorectal Cancer.Int J Mol Sci. 2021 Jan 13;22(2):716. doi: 10.3390/ijms22020716. Int J Mol Sci. 2021. PMID: 33450835 Free PMC article. Review.
-
Exploiting unique features of the gut-brain interface to combat gastrointestinal cancer.J Clin Invest. 2021 May 17;131(10):e143776. doi: 10.1172/JCI143776. J Clin Invest. 2021. PMID: 33998603 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous